Profiles on Cardiovascular and Diabetes

Published within

« | 1 | 2 | 3 | 4 | 5 | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Amylin Pharmaceuticals, LLC

Amylin Pharmaceuticals, LLC (Amylin or 'the company'), a wholly-owned subsidiary of Bristol-Myers Squibb (BMS), is a biopharmaceutical company engaged in the development of potential therapies to treat diabetes and obesity. Amylin currently markets Byetta, Symlin and Bydureon for the treatment of diabetes. The company primarily operates in the US, where it is headquartered in San Diego, California. It employed about 1,300 people as of December 31, 2011.

Published By MarketLine
08 Jan 2013 $175
Buy
Company Profile
Company Profile

Actavis, Inc.

Actavis (or 'the company'), formerly known as Watson Pharmaceuticals, is an integrated global specialty pharmaceutical company focused on the development, manufacture, marketing, sale and distribution of generic, branded and biosimilar products. In January 2013, Watson Pharmaceuticals changed its name to Actavis, Inc. The company operates in the Americas, Europe and Asia. Actavis is headquartered in Parsippany, New Jersey, and employed 17,700 people as of December 31, 2012.

Published By MarketLine
27 Aug 2013 $175
Buy
Company Profile
Company Profile

CJ CheilJedang Corp.

CJ CheilJedang Corp. (CJ CheilJedang or 'the company') is engaged in food, life science and logistics businesses. The company's product portfolio includes food ingredient and other food products such as sugar, flour, edible oil, seasonings, sauces, instant foods, instant cooked rice, fried dumplings, noodles and hams among others. CJ CheilJedang operates in Asia, Australia, the US, the Philippines and Brazil. It is headquartered in Jung-gu, South Korea, and employs about 4,514 people.

Published By MarketLine
12 Sep 2013 $175
Buy
Company Profile
Company Profile

Dyax Corporation

Dyax Corp. (Dyax or 'the company') is a development-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies that address unmet needs with an emphasis on inflammatory indications. The company is headquartered in Cambridge, Massachusetts, and employed 125 people as of February 01, 2013.

Published By MarketLine
20 Sep 2013 $175
Buy
Company Profile
Company Profile

Genzyme Corporation

Genzyme (or 'the company'), a Sanofi company, is one of the world's leading biotechnology companies. The company offers medicines for rare inherited disorders, kidney diseases, orthopaedics, cancer, and transplant and immune disease. Genzyme primarily operates in the Americas and Europe. It is headquartered in Cambridge, Massachusetts.

Published By MarketLine
09 Oct 2013 $175
Buy
Company Profile
Company Profile

Gilead Sciences, Inc.

Gilead Sciences (Gilead or 'the company') is a biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions. The company operates in North America, Europe and Australia. It is headquartered in Foster City, California, and employed about 5,000 people as of January 31, 2013.

Published By MarketLine
09 Oct 2013 $175
Buy
Company Profile
Company Profile

Ipsen S.A.

Ipsen (or 'the group') is a global biopharmaceutical group with products in targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. The group primarily operates in Europe and North America. It is headquartered in Boulogne-Billancourt, France, and employed 4,835 people as of December 31, 2012.

Published By MarketLine
09 Oct 2013 $175
Buy
Company Profile
Company Profile

Gedeon Richter Plc

Gedeon Richter (or 'the group') is engaged in the research, development and production of pharmaceutical products. The group is also involved in the wholesale and retail marketing of its products. It operates in Hungary, other European Union (EU) countries, the US, and the Commonwealth of Independent States (CIS). Gedeon Richter is headquartered in Budapest, Hungary, and employed 11,103 people as of December 31, 2012.

Published By MarketLine
24 Oct 2013 $175
Buy
Company Profile
Company Profile

Celgene Corporation

Celgene (or 'the company'), an integrated biopharmaceutical company, is engaged in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company operates in the US, Europe and Asia Pacific. It is headquartered in Summit, New Jersey, and employed 4,700 people as of December 31, 2012.

Published By MarketLine
28 Oct 2013 $175
Buy
Company Profile
Company Profile

Biogen Idec, Inc.

Biogen Idec (Biogen or 'the company') is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of oncology, neurology and immunology. The company's key products include Tysabri (natalizumab), Avonex (Interferon beta-1a), and Rituxan (rituximab). The company primarily operates in the US and Europe. It is headquartered in Weston, Massachusetts and employed about 5,950 people as of December 31, 2012

Published By MarketLine
28 Oct 2013 $175
Buy

« | 1 | 2 | 3 | 4 | 5 | » »|

No help is available.